Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 6, 2009, Pages 755-761

  Daubert, James P ^a,f   Winters, Stephen L ^d   SubaČius, Haris ^e   Berger, Ronald D ^c   Ellenbogen, Kenneth A ^b   Taylor, Sarah G ^a   Schaechter, Andi ^e   Howard, Adam ^e   Kadish, Alan ^e  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d MORRISTOWN MEMORIAL HOSPITAL   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Congestive heart failure; Dilated cardiomyopathy; Electrophysiology clinical; ICD; Left ventricular dysfunction; Physiopathology; Sudden cardiac death; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; INCIDENCE; MALE; MYOCARDIAL ISCHEMIA; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR; UNITED STATES;

EID: 66949139764     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02362.x     Document Type: Article

References (18)

1. Kadish A, Dyer A, Daubert JP, Quigg R, Estes M, Anderson KP, Calkins H, et al., for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004 350 : 2151 2158. (Pubitemid 38637995)
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al., the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237. (Pubitemid 40110811)
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, Marco TD, Carson P, et al., for the Comparison of Medical Therapy P, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 : 2140 2150.
4. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 2000 342 : 1937 1945. (Pubitemid 30419088)
5. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in multicenter automatic defibrillator implantation trial (MADIT) II patients. J Am Coll Cardiol 2006 47 : 98 107. (Pubitemid 43005171)
6. Buxton AE, Lee KL, Hafley GE, Wyse DG, Fisher JD, Lehmann MH, Pires LA, et al., for the MUSTT Investigators. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: An analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 2002 106 : 2466 2472. (Pubitemid 35278803)
7. Das SK, Morady F, DiCarlo L Jr., Baerman J, Krol R, De Buitleir M, Crevey B. Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol 1986 58 : 998 1000. (Pubitemid 17175841)
8. Poll DS, Marchlinski FE, Buxton AE, Josephson ME. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986 58 : 992 997. (Pubitemid 17175840)
9. Grimm W, Hoffmann J, Menz V, Luck K, Maisch B. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol 1998 32 : 739 745. (Pubitemid 28435263)
10. Brembilla-Perrot B, Donetti J, de la Chaise AT, Sadoul N, Aliot E, Juilliere Y. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991 121 : 1124 1131.
11. Cappato R, Negroni S, Bentivegna S, Bianchetti F, Pecora D, Morandi F, Furlanello F. Role of implantable cardioverter defibrillators in dilated cardiomyopathy. J Cardiovasc Electrophysiol 2002 13 : S106 S109.
12. Grimm W, Christ M, Bach J, Muller H-H, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation 2003 108 : 2883 2891. (Pubitemid 37517816)
13. Becker R, Haass M, Ick D, Krueger C, Bauer A, Senges-Becker JC, Voss F, et al. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy. Basic Res Cardiol 2003 98 : 259 266. (Pubitemid 36874025)
14. Turitto G, Ahuja RK, Caref EB, el-Sherif N. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: Role of programmed ventricular stimulation and the signal-averaged electrocardiogram. J Am Coll Cardiol 1994 24 : 1523 1528. (Pubitemid 24344249)
15. Grimm W, Hoffmann JJ, Muller HH, Maisch B. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. [see comment]. J Am Coll Cardiol 2002 39 : 780 787. (Pubitemid 34185323)
16. Brembilla-Perrot B, Suty-Selton C, Beurrier D, Houriez P, Nippert M, Terrier de la Chaise A, Louis P, et al. Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing. J Am Coll Cardiol 2004 44 : 594 601. (Pubitemid 39078186)
17. Kleiman RB, Callans DJ, Hook BG, Marchlinski FE. Effectiveness of noninvasive programmed stimulation for initiating ventricular tachyarrhythmias in patients with third-generation implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1994 17 : 1462 1468. (Pubitemid 24271497)
18. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008 51 : 288 296.